首页 | 本学科首页   官方微博 | 高级检索  
     

颈动脉粥样硬化差异基因筛选及小檗碱干预颈动脉粥样硬化机制的生物信息学研究
引用本文:张金霞,王玉涛,孙岩. 颈动脉粥样硬化差异基因筛选及小檗碱干预颈动脉粥样硬化机制的生物信息学研究[J]. 中国动脉硬化杂志, 2022, 30(2): 117-124
作者姓名:张金霞  王玉涛  孙岩
作者单位:滨州市第二人民医院药学部;济南市中医医院周围血管病科;山东第一医科大学附属省立医院血管外科
基金项目:山东省中医药科技发展计划(2019-0303);山东省医药卫生科技发展计划(2018WS478、2018WS273);济南市第二届优秀卫生计生人才培养项目(济卫科外发〔2018〕8号);济南市第三批“薪火传承231工程”培养项目(济中医药发〔2017〕11号);济南市卫生健康系统青年岗位能手培养项目(济卫发〔2019〕1号);济南市卫生健康委员会科技计划项目(2019-1-23)。
摘    要:目的以生物信息学方法探讨颈动脉粥样硬化发病新的潜在机制,挖掘小檗碱干预颈动脉粥样硬化的潜在靶点和途径。方法检索获取美国国家生物技术信息中心基因表达综合数据库并获取颈动脉粥样硬化斑块基因表达芯片GSE28829数据集,筛选样本差异表达基因数据并进行富集分析;检索获取小檗碱的潜在作用靶点,与颈动脉粥样硬化差异表达基因取交集,获得小檗碱干预颈动脉粥样硬化的潜在靶点,进行富集分析并筛选核心靶点。结果共筛选获得颈动脉粥样硬化差异表达基因174个,涉及趋化因子、核因子κB、Toll样受体、脂肪酸降解等信号通路。筛选获得小檗碱干预颈动脉粥样硬化的潜在靶点5个,涉及流体剪切力与动脉硬化、白细胞介素17、肿瘤坏死因子等信号通路,经拓扑及富集分析,CCL2、HMOX1和MMP-9可能是小檗碱干预颈动脉粥样硬化的核心靶点。结论颈动脉粥样硬化差异表达基因主要富集于炎性反应、脂质代谢等信号通路;小檗碱可能通过介导CCL2、HMOX1、MMP-9等靶点调控流体剪切力、白细胞介素17、肿瘤坏死因子等信号通路而干预颈动脉粥样硬化。

关 键 词:颈动脉粥样硬化  小檗碱  信号通路  生物信息学
收稿时间:2021-04-07
修稿时间:2021-09-01

The bioinformatics research of differentia gene expression in carotid atherosclerosis and potential mechanism of berberine intervening carotid atherosclerosis
ZHANG Jinxi,WANG Yutao,SUN Yan. The bioinformatics research of differentia gene expression in carotid atherosclerosis and potential mechanism of berberine intervening carotid atherosclerosis[J]. Chinese Journal of Arteriosclerosis, 2022, 30(2): 117-124
Authors:ZHANG Jinxi  WANG Yutao  SUN Yan
Affiliation:(Department of Pharmacy,the Second People's Hospital of Binzhou,Binzhou,Shandong 256600,China;Department of Peripheral Vascular Disease,Ji'nan Municipal Hospital of Traditional Chinese Medicine,Ji'nan,Shandong 250012,China;Department of Vascular Surgery,Shandong Provincial Hospital Affiliated to Shandong First Medical University,Ji'nan,Shandong 250021,China)
Abstract:Aim To investigate the new potential mechanisms of carotid atherosclerosis pathogenesis and explore the potential targets and pathways of berberine intervention in carotid atherosclerosis by bioinformatic research.Methods The study searched the Gene Expression Omnibus database of the National Center for Biotechnology Information(NCBI)and obtained the GSE28829 datasets of carotid atherosclerosis plaque gene expression microarray,screened the sample differentially expressed gene data for enrichment analysis.The potential targets of berberine were searched and obtained to be intersected with the differentially expressed genes of carotid atherosclerosis in order to obtain the potential targets of berberine intervention in carotid atherosclerosis.Enrichment analysis was performed and the core targets were screened.Results A total of 174 differentially expressed genes in carotid atherosclerosis were screened,involving chemokines,nuclear factor kappa B,Toll-like receptors,fatty acid degradation and other signaling pathways.Five potential targets of berberine in carotid atherosclerosis were screened,involving fluid shear and atherosclerosis,interleukin-17,tumor necrosis factor and other signaling pathways.Monocyte chemoattractant protein-1(MCP-1/CCL2),heme oxygenase 1(HO-1/HMOX1)and matrix metalloproteinase-9(MMP-9)were identified as the core targets of berberine intervening carotid atherosclerosis by topology and enrichment analysis.Conclusions Differentially expressed genes in carotid atherosclerosis are mainly enriched in signaling pathways such as inflammatory response and lipid metabolism;berberine may intervene in carotid atherosclerosis by mediating targets such as CCL2,HMOX1,MMP-9,and regulating fluid shear and atherosclerosis,interleukin-17,and tumor necrosis factor and other signaling pathways.
Keywords:carotid atherosclerosis  berberine  signaling pathway  bioinformatics
本文献已被 维普 等数据库收录!
点击此处可从《中国动脉硬化杂志》浏览原始摘要信息
点击此处可从《中国动脉硬化杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号